FIVE BELOW (FIVE) Fundamental Analysis & Valuation

NASDAQ:FIVE • US33829M1018

219.9 USD
+1.36 (+0.62%)
Last: Mar 12, 2026, 02:15 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This FIVE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

6

Overall FIVE gets a fundamental rating of 6 out of 10. We evaluated FIVE against 124 industry peers in the Specialty Retail industry. While FIVE has a great health rating, its profitability is only average at the moment. FIVE is valued quite expensively, but it does show have an excellent growth rating. These ratings could make FIVE a good candidate for growth investing.


Dividend Valuation Growth Profitability Health

6

1. FIVE Profitability Analysis

1.1 Basic Checks

  • In the past year FIVE was profitable.
  • In the past year FIVE had a positive cash flow from operations.
  • Each year in the past 5 years FIVE has been profitable.
  • Each year in the past 5 years FIVE had a positive operating cash flow.
FIVE Yearly Net Income VS EBIT VS OCF VS FCFFIVE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M

1.2 Ratios

  • The Return On Assets of FIVE (6.43%) is better than 78.23% of its industry peers.
  • The Return On Equity of FIVE (15.79%) is better than 75.00% of its industry peers.
  • FIVE has a better Return On Invested Capital (7.99%) than 70.97% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for FIVE is significantly below the industry average of 13.57%.
Industry RankSector Rank
ROA 6.43%
ROE 15.79%
ROIC 7.99%
ROA(3y)7.16%
ROA(5y)7.3%
ROE(3y)17.41%
ROE(5y)18.22%
ROIC(3y)8.48%
ROIC(5y)9.59%
FIVE Yearly ROA, ROE, ROICFIVE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • FIVE's Profit Margin of 6.96% is amongst the best of the industry. FIVE outperforms 83.87% of its industry peers.
  • FIVE's Profit Margin has declined in the last couple of years.
  • FIVE has a better Operating Margin (8.88%) than 79.84% of its industry peers.
  • FIVE's Operating Margin has declined in the last couple of years.
  • FIVE has a Gross Margin (35.63%) which is in line with its industry peers.
  • FIVE's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 8.88%
PM (TTM) 6.96%
GM 35.63%
OM growth 3Y-21.23%
OM growth 5Y-6.62%
PM growth 3Y-12.57%
PM growth 5Y-7.15%
GM growth 3Y-1.19%
GM growth 5Y-0.89%
FIVE Yearly Profit, Operating, Gross MarginsFIVE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. FIVE Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so FIVE is destroying value.
  • FIVE has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for FIVE has been reduced compared to 5 years ago.
  • FIVE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
FIVE Yearly Shares OutstandingFIVE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
FIVE Yearly Total Debt VS Total AssetsFIVE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.2 Solvency

  • An Altman-Z score of 4.43 indicates that FIVE is not in any danger for bankruptcy at the moment.
  • FIVE has a Altman-Z score of 4.43. This is amongst the best in the industry. FIVE outperforms 84.68% of its industry peers.
  • There is no outstanding debt for FIVE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 4.43
ROIC/WACC0.83
WACC9.67%
FIVE Yearly LT Debt VS Equity VS FCFFIVE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B

2.3 Liquidity

  • FIVE has a Current Ratio of 1.60. This is a normal value and indicates that FIVE is financially healthy and should not expect problems in meeting its short term obligations.
  • FIVE has a Current ratio of 1.60. This is in the better half of the industry: FIVE outperforms 65.32% of its industry peers.
  • FIVE has a Quick Ratio of 1.60. This is a bad value and indicates that FIVE is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.59, FIVE perfoms like the industry average, outperforming 55.65% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.6
Quick Ratio 0.59
FIVE Yearly Current Assets VS Current LiabilitesFIVE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. FIVE Growth Analysis

3.1 Past

  • FIVE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 11.90%, which is quite good.
  • FIVE shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 10.07% yearly.
  • FIVE shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 15.78%.
  • FIVE shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.99% yearly.
EPS 1Y (TTM)11.9%
EPS 3Y0.6%
EPS 5Y10.07%
EPS Q2Q%61.9%
Revenue 1Y (TTM)15.78%
Revenue growth 3Y10.82%
Revenue growth 5Y15.99%
Sales Q2Q%23.06%

3.2 Future

  • The Earnings Per Share is expected to grow by 30.76% on average over the next years. This is a very strong growth
  • FIVE is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 16.48% yearly.
EPS Next Y28.27%
EPS Next 2Y18.51%
EPS Next 3Y16.14%
EPS Next 5Y30.76%
Revenue Next Year22.34%
Revenue Next 2Y16.08%
Revenue Next 3Y13.92%
Revenue Next 5Y16.48%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
FIVE Yearly Revenue VS EstimatesFIVE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2B 4B 6B 8B
FIVE Yearly EPS VS EstimatesFIVE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 5 10 15 20

More info and screens

Find the best growth stocksShow best growing peers

3

4. FIVE Valuation Analysis

4.1 Price/Earnings Ratio

  • FIVE is valuated quite expensively with a Price/Earnings ratio of 37.72.
  • Compared to the rest of the industry, the Price/Earnings ratio of FIVE is on the same level as its industry peers.
  • The average S&P500 Price/Earnings ratio is at 26.15. FIVE is valued slightly more expensive when compared to this.
  • A Price/Forward Earnings ratio of 31.06 indicates a quite expensive valuation of FIVE.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of FIVE is on the same level as its industry peers.
  • When comparing the Price/Forward Earnings ratio of FIVE to the average of the S&P500 Index (24.27), we can say FIVE is valued slightly more expensively.
Industry RankSector Rank
PE 37.72
Fwd PE 31.06
FIVE Price Earnings VS Forward Price EarningsFIVE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as FIVE.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of FIVE is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 37.56
EV/EBITDA 19.52
FIVE Per share dataFIVE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

  • FIVE's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The decent profitability rating of FIVE may justify a higher PE ratio.
  • A more expensive valuation may be justified as FIVE's earnings are expected to grow with 16.14% in the coming years.
PEG (NY)1.33
PEG (5Y)3.75
EPS Next 2Y18.51%
EPS Next 3Y16.14%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. FIVE Dividend Analysis

5.1 Amount

  • No dividends for FIVE!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

FIVE Fundamentals: All Metrics, Ratios and Statistics

FIVE BELOW

NASDAQ:FIVE (3/12/2026, 2:15:49 PM)

219.9

+1.36 (+0.62%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)12-03
Earnings (Next)06-02
Inst Owners105.59%
Inst Owner Change95.16%
Ins Owners0.85%
Ins Owner Change-2.88%
Market Cap12.13B
Revenue(TTM)4.43B
Net Income(TTM)307.87M
Analysts76.25
Price Target221.17 (0.58%)
Short Float %3.99%
Short Ratio2.09
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)101.66%
Min EPS beat(2)29.03%
Max EPS beat(2)174.29%
EPS beat(4)4
Avg EPS beat(4)51.97%
Min EPS beat(4)1.27%
Max EPS beat(4)174.29%
EPS beat(8)5
Avg EPS beat(8)42.48%
EPS beat(12)7
Avg EPS beat(12)29.19%
EPS beat(16)8
Avg EPS beat(16)27.52%
Revenue beat(2)2
Avg Revenue beat(2)2.62%
Min Revenue beat(2)1.37%
Max Revenue beat(2)3.87%
Revenue beat(4)2
Avg Revenue beat(4)0.63%
Min Revenue beat(4)-1.55%
Max Revenue beat(4)3.87%
Revenue beat(8)3
Avg Revenue beat(8)-0.28%
Revenue beat(12)3
Avg Revenue beat(12)-0.63%
Revenue beat(16)4
Avg Revenue beat(16)-0.91%
PT rev (1m)2.8%
PT rev (3m)19.88%
EPS NQ rev (1m)1.58%
EPS NQ rev (3m)16.39%
EPS NY rev (1m)1.39%
EPS NY rev (3m)22.23%
Revenue NQ rev (1m)-0.06%
Revenue NQ rev (3m)6.64%
Revenue NY rev (1m)0.06%
Revenue NY rev (3m)3.52%
Valuation
Industry RankSector Rank
PE 37.72
Fwd PE 31.06
P/S 2.74
P/FCF 37.56
P/OCF 23.83
P/B 6.22
P/tB 6.22
EV/EBITDA 19.52
EPS(TTM)5.83
EY2.65%
EPS(NY)7.08
Fwd EY3.22%
FCF(TTM)5.86
FCFY2.66%
OCF(TTM)9.23
OCFY4.2%
SpS80.25
BVpS35.36
TBVpS35.36
PEG (NY)1.33
PEG (5Y)3.75
Graham Number68.1
Profitability
Industry RankSector Rank
ROA 6.43%
ROE 15.79%
ROCE 10.65%
ROIC 7.99%
ROICexc 9.31%
ROICexgc 9.31%
OM 8.88%
PM (TTM) 6.96%
GM 35.63%
FCFM 7.3%
ROA(3y)7.16%
ROA(5y)7.3%
ROE(3y)17.41%
ROE(5y)18.22%
ROIC(3y)8.48%
ROIC(5y)9.59%
ROICexc(3y)9.94%
ROICexc(5y)11.39%
ROICexgc(3y)9.94%
ROICexgc(5y)11.39%
ROCE(3y)11.31%
ROCE(5y)12.79%
ROICexgc growth 3Y-24.82%
ROICexgc growth 5Y-8.07%
ROICexc growth 3Y-24.82%
ROICexc growth 5Y-8.07%
OM growth 3Y-21.23%
OM growth 5Y-6.62%
PM growth 3Y-12.57%
PM growth 5Y-7.15%
GM growth 3Y-1.19%
GM growth 5Y-0.89%
F-Score9
Asset Turnover0.92
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 98.65%
Cap/Sales 4.2%
Interest Coverage 250
Cash Conversion 87.48%
Profit Quality 104.9%
Current Ratio 1.6
Quick Ratio 0.59
Altman-Z 4.43
F-Score9
WACC9.67%
ROIC/WACC0.83
Cap/Depr(3y)229.46%
Cap/Depr(5y)263.43%
Cap/Sales(3y)8.65%
Cap/Sales(5y)9.26%
Profit Quality(3y)40.25%
Profit Quality(5y)53.87%
High Growth Momentum
Growth
EPS 1Y (TTM)11.9%
EPS 3Y0.6%
EPS 5Y10.07%
EPS Q2Q%61.9%
EPS Next Y28.27%
EPS Next 2Y18.51%
EPS Next 3Y16.14%
EPS Next 5Y30.76%
Revenue 1Y (TTM)15.78%
Revenue growth 3Y10.82%
Revenue growth 5Y15.99%
Sales Q2Q%23.06%
Revenue Next Year22.34%
Revenue Next 2Y16.08%
Revenue Next 3Y13.92%
Revenue Next 5Y16.48%
EBIT growth 1Y13.83%
EBIT growth 3Y-12.71%
EBIT growth 5Y8.3%
EBIT Next Year86.56%
EBIT Next 3Y31.72%
EBIT Next 5Y30.4%
FCF growth 1Y128.3%
FCF growth 3Y39.02%
FCF growth 5YN/A
OCF growth 1Y12.68%
OCF growth 3Y9.51%
OCF growth 5Y18.16%

FIVE BELOW / FIVE FAQ

What is the ChartMill fundamental rating of FIVE BELOW (FIVE) stock?

ChartMill assigns a fundamental rating of 6 / 10 to FIVE.


What is the valuation status of FIVE BELOW (FIVE) stock?

ChartMill assigns a valuation rating of 3 / 10 to FIVE BELOW (FIVE). This can be considered as Overvalued.


Can you provide the profitability details for FIVE BELOW?

FIVE BELOW (FIVE) has a profitability rating of 6 / 10.


What are the PE and PB ratios of FIVE BELOW (FIVE) stock?

The Price/Earnings (PE) ratio for FIVE BELOW (FIVE) is 37.72 and the Price/Book (PB) ratio is 6.22.


Is the dividend of FIVE BELOW sustainable?

The dividend rating of FIVE BELOW (FIVE) is 0 / 10 and the dividend payout ratio is 0%.